# SCOPE: Selective Critical-Step On-Policy Self-Distillation for Agentic Reinforcement Learning

Preprint · Qirui Liu, Wei Cao, Yu Mi, Yichen Sun, Xuekun Zhang, Lei Liu, Yue Shen, Zhixuan Chu

- Archive id: arxiv:2610.38391
- Published: 2026-10-28
- arXiv: https://arxiv.org/abs/2610.38391
- Source URL: https://arxiv.org/abs/2610.38391
- PDF: https://arxiv.org/pdf/2610.38391
- Provenance: arxiv

## Abstract

Outcome-based reinforcement learning provides coarse supervision for long-horizon LLM agents: failed trajectories may contain correct steps, while successful trajectories can contain errors. Trajectory-level skills can also shift teacher preferences at unrelated steps, introducing off-target distillation signals. We introduce SCOPE, a framework for Selective Critical-Step On-Policy Self-Distillation. After a supervised warm-up, the policy analyzes its own trajectories, generates step-specific hindsight skills, and distills their guidance only at selected error steps. A bounded signed teacher-student coefficient stabilizes auxiliary updates while preserving positive reinforcement and negative correction. A success-relative pairwise length reward further encourages efficient task completion. Experiments on ALFWorld and WebShop demonstrate consistent improvements across multiple model backbones. With Qwen2.5-3B, SCOPE achieves 97.7% success on ALFWorld and 85.2% on WebShop, outperforming SEED by 5.9 and 6.3 percentage points, respectively. On unseen ALFWorld tasks, SCOPE reaches 89.6% success, improving over GRPO by 23.2 percentage points with 46.7% fewer interactions. Scaling to Qwen3-32B, SCOPE achieves 99.2% success on seen ALFWorld tasks and 94.0% on unseen tasks.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

Topics: [LLM Agents & Tool Use](https://space-kitty.com/topics/ai-agents)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.